*ST越博(300742) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥69,354,437.30, a decrease of 34.49% compared to ¥105,867,175.70 in the same period last year[5] - The net profit attributable to shareholders was -¥19,161,981.47, representing a decline of 16.08% from -¥16,508,004.41 year-on-year[5] - Total operating revenue for Q1 2023 was CNY 69,354,437.30, a decrease of 34.3% compared to CNY 105,867,175.70 in the same period last year[21] - Net loss for Q1 2023 was CNY 20,663,244.16, compared to a net loss of CNY 18,266,342.78 in Q1 2022, reflecting a decline in profitability[22] - Basic and diluted earnings per share for Q1 2023 were both CNY -0.1356, compared to CNY -0.1168 in Q1 2022, indicating a worsening in earnings per share[23] Cash Flow - The cash flow from operating activities showed a net outflow of -¥11,718,255.10, a significant decrease of 190.90% compared to a positive cash flow of ¥12,891,747.21 in Q1 2022[5] - The net cash flow from operating activities for the current period is -11,718,255.10 CNY, a decrease from 12,891,747.21 CNY in the previous period[26] - Total cash inflow from operating activities is 61,442,942.50 CNY, down 50.9% from 125,173,387.12 CNY in the previous period[26] - Cash outflow from operating activities is 73,161,197.60 CNY, a decrease of 34.8% compared to 112,281,639.91 CNY in the previous period[26] - The net cash flow from investing activities is -11,396,422.84 CNY, worsening from -8,575,890.06 CNY in the previous period[26] - Cash inflow from investing activities is 653,061.20 CNY, up from 281,415.94 CNY in the previous period[26] - Cash outflow from investing activities increased to 12,049,484.04 CNY from 8,857,306.00 CNY in the previous period[26] - The net cash flow from financing activities is 21,926,470.87 CNY, improving from -1,336,802.74 CNY in the previous period[26] - Cash inflow from financing activities is 29,850,000.00 CNY, down from 199,105,686.31 CNY in the previous period[26] - The ending cash and cash equivalents balance is 1,056,408.24 CNY, significantly lower than 6,557,257.17 CNY in the previous period[26] Assets and Liabilities - Total assets increased by 10.37% to ¥1,349,163,372.87 from ¥1,222,455,341.03 at the end of the previous year[5] - Total liabilities rose to CNY 1,458,178,607.52, compared to CNY 1,312,369,493.22 in the same period last year, indicating increased financial obligations[19] - The company's total non-current liabilities increased to CNY 103,881,545.11, compared to CNY 52,179,862.21 in the previous year, reflecting a significant rise in long-term obligations[19] - The total equity attributable to shareholders of the parent company was CNY -106,349,634.66, compared to CNY -83,599,062.74 in the same period last year, indicating a decline in shareholder equity[19] Shareholder Information - The company has a total of 16,216 common shareholders as of the report date[10] - Major shareholder Li Zhanjiang holds 24.66% of the shares, with 34,838,277 shares pledged[11] - The top 10 unrestricted shareholders hold a total of 11,088,000 shares, with the largest shareholder owning 8,340,511 shares[12] - The company has 34,838,277 shares under lock-up, with 5,979,570 shares newly added during the reporting period[14] Risk and Warnings - The company reported a net asset of -83,599,062.74 RMB as of the end of 2022, leading to a risk warning for potential delisting due to negative net assets[15] - The company's stock is currently under a delisting risk warning, indicated by the "*ST" prefix on its stock name[15] - The company's financial position remains under scrutiny due to the negative net asset situation, impacting investor confidence[15] Operational Metrics - The company reported a 31.06% increase in accounts receivable, reaching ¥296,342,579.82 due to income not yet settled[9] - As of March 31, 2023, accounts receivable increased to 296,342,579.82 RMB from 226,110,072.23 RMB at the beginning of the year, reflecting a growth of approximately 31%[17] - The company has a significant increase in prepayments, rising to 31,255,025.72 RMB from 25,338,995.20 RMB, indicating a growth of approximately 23%[17] - The company’s other receivables decreased to 3,196,704.16 RMB from 9,439,178.76 RMB, showing a decline of about 66%[17] Research and Development - Research and development expenses decreased by 31.58% to ¥4,178,633.48 compared to ¥6,107,358.68 in Q1 2022[9] - Research and development expenses for Q1 2023 were CNY 4,178,633.48, down 31.7% from CNY 6,107,358.68 in the previous year[22] Product Development and Strategy - The company has not disclosed any new product developments or market expansion strategies in the current report[14]